192 related articles for article (PubMed ID: 9046365)
1. Management of hemophilias--gene therapy to come?
Vajó Z; Sréter L
Acta Physiol Hung; 1996; 84(2):191-8. PubMed ID: 9046365
[TBL] [Abstract][Full Text] [Related]
2. The hemophilias--from royal genes to gene therapy.
Mannucci PM; Tuddenham EG
N Engl J Med; 2001 Jun; 344(23):1773-9. PubMed ID: 11396445
[No Abstract] [Full Text] [Related]
3. [New approaches to haemophilia treatment--recombinant and transgenic concentrates, gene therapy and engineered coagulation factors].
Habart D
Cas Lek Cesk; 2006; 145(2):104-11. PubMed ID: 16521398
[TBL] [Abstract][Full Text] [Related]
4. State and prospects of gene therapy for the hemophilias.
Fallaux FJ; Hoeben RC; Briët E
Thromb Haemost; 1995 Jul; 74(1):266-73. PubMed ID: 8578470
[No Abstract] [Full Text] [Related]
5. Current status of gene therapy for hemophilia.
Nathwani AC; Nienhuis AW; Davidoff AM
Curr Hematol Rep; 2003 Jul; 2(4):319-27. PubMed ID: 12901329
[TBL] [Abstract][Full Text] [Related]
6. Gene therapy progress and prospects: gene therapy for the hemophilias.
Walsh CE
Gene Ther; 2003 Jun; 10(12):999-1003. PubMed ID: 12776156
[TBL] [Abstract][Full Text] [Related]
7. Hemophilia gene therapy: novel rAAV vectors and RNA repair strategy.
Chao H; Walsh CE
Curr Opin Mol Ther; 2002 Oct; 4(5):499-504. PubMed ID: 12435052
[TBL] [Abstract][Full Text] [Related]
8. Progress towards gene therapy for the hemophilias.
Thompson AR
Thromb Haemost; 1995 Jul; 74(1):45-51. PubMed ID: 8578505
[TBL] [Abstract][Full Text] [Related]
9. An update on gene therapy for hemophilia.
Nathwani AC; McIntosh J; Davidoff AM
Curr Hematol Rep; 2005 Jul; 4(4):287-93. PubMed ID: 16009043
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy for hemophilia.
Lynch CM
Curr Opin Mol Ther; 1999 Aug; 1(4):493-9. PubMed ID: 11713765
[TBL] [Abstract][Full Text] [Related]
11. The treatment of hemophilia A: from protein replacement to AAV-mediated gene therapy.
Youjin S; Jun Y
Biotechnol Lett; 2009 Mar; 31(3):321-8. PubMed ID: 18979215
[TBL] [Abstract][Full Text] [Related]
12. Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia.
High KA
Trans Am Clin Climatol Assoc; 2003; 114():337-51; discussion 351-2. PubMed ID: 12813929
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy for hemophilia A.
Connelly S; Kaleko M
Thromb Haemost; 1997 Jul; 78(1):31-6. PubMed ID: 9198123
[TBL] [Abstract][Full Text] [Related]
14. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors.
Snyder RO; Miao CH; Patijn GA; Spratt SK; Danos O; Nagy D; Gown AM; Winther B; Meuse L; Cohen LK; Thompson AR; Kay MA
Nat Genet; 1997 Jul; 16(3):270-6. PubMed ID: 9207793
[TBL] [Abstract][Full Text] [Related]
15. New high-technology products for the treatment of haemophilia.
Pipe SW; Saint-Remy JM; Walsh CE
Haemophilia; 2004 Oct; 10 Suppl 4():55-63. PubMed ID: 15479373
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy for hemophilia: clinical trials and technical tribulations.
Viiala NO; Larsen SR; Rasko JE
Semin Thromb Hemost; 2009 Feb; 35(1):81-92. PubMed ID: 19308896
[TBL] [Abstract][Full Text] [Related]
17. [Current status and future prospects of hemophilia treatment].
Lopaciuk S
Acta Haematol Pol; 1995; 26(2 Suppl 1):44-55. PubMed ID: 7653234
[TBL] [Abstract][Full Text] [Related]
18. Preclinical and clinical gene therapy for haemophilia.
Chuah MK; Collen D; Vandendriessche T
Haemophilia; 2004 Oct; 10 Suppl 4():119-25. PubMed ID: 15479384
[TBL] [Abstract][Full Text] [Related]
19. Management of hemophilia in France.
Allain JP
Thromb Haemost; 1976 Jun; 35(3):553-8. PubMed ID: 989961
[TBL] [Abstract][Full Text] [Related]
20. Recombinant factor VIII in hemophilia A: the Canadian experience.
Blanchette VS
Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S33-9. PubMed ID: 9351535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
